In Vitro Diagnosis Market

In Vitro Diagnosis (IVD), is also known as In Vitro Diagnostic. It refers to outside the human body, through the human body sample (blood, body fluids, tissues, etc.) to obtain clinical diagnostic information, and then determine the disease or body function of products and services.In vitro diagnostic products are mainly composed of diagnostic equipment (instruments) and diagnostic reagents.

In Vitro Diagnosis Market contains market size and forecasts of In Vitro Diagnosis (IVD) in Global, including the following market information:

• Global In Vitro Diagnosis (IVD) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global In Vitro Diagnosis (IVD) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

by Product Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of In Vitro Diagnosis (IVD) include Roche, Abbott, Danaher, Siemens, Thermo Fisher Scientific, Sysmex, Biomerieux, Ortho Clinical Diagnostics and Becton Dickinson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the In Vitro Diagnosis (IVD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global In Vitro Diagnosis (IVD) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global In Vitro Diagnosis (IVD) Market Segment Percentages, by Type, 2021 (%)

by Product Type

• In Vitro Diagnostic Reagents
• In Vitro Diagnostic Instruments

by Diagnostic Method

• Immunoassays
• Molecular diagnostics involves
• Point-of-care testing (POCT)
• chemistry Diagnosis

Global In Vitro Diagnosis (IVD) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global In Vitro Diagnosis (IVD) Market Segment Percentages, by Application, 2021 (%)

• Physical Examination
• Chronic Disease Management
• Heavy Disease Surveillance

Global In Vitro Diagnosis (IVD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global In Vitro Diagnosis (IVD) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies In Vitro Diagnosis (IVD) revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies In Vitro Diagnosis (IVD) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Abbott
• Danaher
• Siemens
• Thermo Fisher Scientific
• Sysmex
• Biomerieux
• Ortho Clinical Diagnostics
• Becton Dickinson
• Bio-Rad Laboratories
• Hologic
• Johnson and Johnson
• Qiagen
• Myriad Genetics
• Wondfo
• KHB
• DAAN Gene
• Leadman Biochemistry
• Mindray
• BioSino
• Diasorin
• Illumina
• Industrial Scientific
• Wantai Biological
• RONGSHENG BIOTECH
• Fosun Group
• Hybribio Biotech
• Kingmed Diagnostics
• Edan Instruments
• COMING Medical